Advanced Modular Drug Delivery System with Real-time Feedback and Wearable Integration

Publication ID: 24-11857554_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Advanced Modular Drug Delivery System with Real-time Feedback and Wearable Integration,” Published Technical Disclosure No. 24-11857554_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857554_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,554.

Summary of the Inventive Concept

A next-generation drug delivery system featuring self-perforating cartridges, real-time flow rate adjustment, integrated sensing, and wearable designs, revolutionizing the precision and convenience of therapeutic substance delivery.

Background and Problem Solved

The original patent's pre-assembled cartridge design, while innovative, has limitations in terms of flow rate control and real-time monitoring. The new inventive concept addresses these limitations by introducing advanced features that enhance the precision, convenience, and wearability of drug delivery devices.

Detailed Description of the Inventive Concept

The advanced modular drug delivery system consists of a body extending from a delivery tip, which defines a cavity for retaining pre-assembled cartridges holding therapeutic substances. The cartridges are self-perforating, eliminating the need for a separate perforator. A manual activator releases a consistent flow of the substance, which can be adjusted in real-time using a feedback control system. An integrated sensing system detects the concentration of the substance in the cartridge, allowing for precise flow rate control. The system can be modular, with interchangeable cartridges holding different therapeutic substances, and can be integrated into wearable designs for extended periods of delivery.

Novelty and Inventive Step

The new claims introduce the concepts of self-perforating cartridges, real-time flow rate adjustment, and integrated sensing, which are not present in the original patent. These features, combined with the modular and wearable designs, provide a significant inventive step forward in the field of drug delivery devices.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of sensors, such as optical or electrochemical sensors, or integrating the system with artificial intelligence for predictive analytics. Variations could also include using different materials for the cartridges or the body of the delivery device, or designing the system for use in specific medical specialties, such as oncology or pediatrics.

Potential Commercial Applications and Market

The advanced modular drug delivery system has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of personalized medicine, precision therapy, and wearable healthcare technology. Target markets could include hospitals, clinics, and pharmaceutical companies, as well as patients requiring long-term or chronic therapy.

Field of Art

Medical device engineering, specifically drug delivery systems and medical device design with expertise in cartridge-based substance delivery mechanisms, mechanical actuation, and pharmaceutical dispensing technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, 3-5 years experience in drug delivery system design, familiar with mechanical perforation techniques, fluid control systems, and medical device miniaturization

Obviousness Rationale

A PHOSITA would recognize the PTD's variations as straightforward extensions of the source patent's core drug delivery device concept, applying known engineering techniques to enhance functionality through modular design, integrated sensing, and automated flow control. The modifications represent predictable improvements using standard design approaches in medical device engineering, leveraging existing mechanical and electronic control principles.

Obvious Combinations & Variations

Source Patent Element
Cartridge with perforator mechanism for substance discharge
PTD Variation
Self-perforating cartridge eliminating separate perforator component
Obviousness Reasoning
Simplifying mechanical interfaces is a standard design optimization approach, reducing part count and potential failure points using known mechanical engineering principles
Source Patent Element
Delivery device with elongated tip for substance transfer
PTD Variation
Integrated sensing system for real-time concentration monitoring and flow rate adjustment
Obviousness Reasoning
Adding electronic feedback control is a predictable enhancement in medical device design, utilizing standard sensor integration techniques to improve precision and user control
Source Patent Element
Pre-assembled cartridge holding therapeutic substance
PTD Variation
Modular design with interchangeable cartridges for different substances
Obviousness Reasoning
Platform design allowing component standardization is a common engineering strategy, creating flexible systems with minimal redesign effort
Source Patent Element
Surgical drug delivery device
PTD Variation
Wearable continuous delivery system with programmable control
Obviousness Reasoning
Extending medical devices into continuous ambulatory applications represents a natural technological progression using known miniaturization and power management techniques
Source Patent Element
Manual substance discharge mechanism
PTD Variation
AI-enhanced predictive analytics for substance delivery optimization
Obviousness Reasoning
Incorporating machine learning into medical device control represents an incremental technological advancement using established software engineering approaches
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857554, the present publication demonstrates that the claimed variations in drug delivery device design would have been obvious to a person having ordinary skill in the art at the time of invention, representing predictable technological improvements using standard engineering methodologies and known techniques in medical device design and substance delivery systems.

Original Patent Information

Patent NumberUS 11,857,554
TitleDrug delivery device with pre-assembled cartridge
Assignee(s)INTRAVITAL PTY LTD.